Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Chemotherapy Chosen By More Older Women With Early Stage Breast Cancer
A new study examining treatment decision-making by older women with early stage breast cancer shows that 45 percent of women would choose to get chemotherapy after surgery -- a figure higher than the national average of women getting the additional treatment.
generic viagra online
$33.9 Billion Spent Out-Of-Pocket On Complementary And Alternative Medicine By Americans
Americans spent $33.9 billion out-of-pocket on complementary and alternative medicine (CAM) over the previous 12 months, according to a 2007 government survey1. CAM is a group of diverse medical and health care systems, practices, and products such as herbal supplements, meditation, chiropractic, and acupuncture that are not generally considered to be part of conventional medicine. CAM accounts for approximately 1.5 percent of total health care expenditures ($2.2 trillion2) and 11.2 percent of total out-of-pocket expenditures (conventional out-of-pocket: $286.6 billion2 and CAM out-of-pocket: $33.9 billion1) on health care in the United States.
News of the day
NHS Trust Focuses On Staff Health
Hydration expert, Water Wellpoint is playing a key role in helping public sector employers look after the health and wellbeing of their staff. The company has recently been working with East London NHS Foundation Trust to run a series of wellbeing days, giving employees the ability to check key aspects of their health in a total voluntary format.
Oncology

Health Canada Approves Innovotech Application For AgressTM Field Testing

The Pest Management Regulatory Agency of Health Canada has granted Innovotech (TSV VENTURE:IOT) a Research Authorization for large-scale field trials for the 2009 season to test its novel seed treatment, AgressTM. This Research Authorization provides growers with an opportunity to assess the real-world ability of AgressTM to fight bacterial disease and its ease of use. In conjunction with cooperating growers, dry beans treated with AgressTM have been planted on farms in Alberta. "These large-scale field trials give us an opportunity to test AgressTM on a commercial scale that would be used by a grower," says Damian Sowa, Product Manager, Innovotech. "We will also use the trials to validate our small plot results that showed AgressTM to be a superior and long sought replacement for Streptomycin in bacterial infestations of beans." Research is currently underway to expand the applications of AgressTM to include the major crops in North America and additional disease classes. Innovotech Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009